A novel combined resveratrol/berberine phytochemotheraputic using the HePG2 cell line as a model for the treatment of hepatocarcinoma

D'Arcy, Mark S. and Pike, Claire V. S. and Coussons, Peter J. (2021) A novel combined resveratrol/berberine phytochemotheraputic using the HePG2 cell line as a model for the treatment of hepatocarcinoma. Cell Biology International, 45 (12). pp. 2499-2509. ISSN 1095-8355

[img] Text
Accepted Version
Restricted to Repository staff only until 30 August 2022.
Available under the following license: Creative Commons Attribution Non-commercial No Derivatives.

Download (2MB) | Request a copy
[img] Text (Word version)
Accepted Version
Restricted to Repository staff only until 30 August 2022.
Available under the following license: Creative Commons Attribution Non-commercial No Derivatives.

Download (16MB) | Request a copy
Official URL: https://doi.org/10.1002/cbin.11695

Abstract

The results presented herein show that at clinically relevant concentrations (0–30 µM), the well-tolerated phytochemical berberine (BER) induces cell death in cultured human hepatocarcinoma (HepG2) cells as a model for liver cancer, primarily via apoptosis. Similar, relatively low-concentration single treatments using the structurally related phytochemical resveratrol (RSV), had little or no effect on cell viability but inhibited the cell cycle, while simultaneously increasing the strength of cellular adhesion. When used in combination, an RSV/BER cotreatment appeared to retain the ability of a single RSV treatment to increase cellular adhesion, but also induced a massive loss in hepatocarcinoma cellular viability, inducing cell death in more than 90% of cells. This model, therefore, suggests that it may be possible to use RSV to stabilise hepatocarcinomas against metastasis while using cotreatment with BER to simultaneously induce cell death. By measuring the changes in the activity of the pleiotropic enzyme transglutaminase 2 (TGM2), which is known to be overexpressed in hepatocarcinoma and many other tumours, we hypothesise a role for this enzyme in the activities of these two phytochemicals, and propose the potential use of this RSV/BER cotreatment as a chemotherapeutic in TGM2+ hepatocarcinomas.

Item Type: Journal Article
Keywords: apoptosis, berberine, cancer, necrosis, resveratrol, transglutaminase 2
Faculty: Faculty of Science & Engineering
Depositing User: Lisa Blanshard
Date Deposited: 02 Nov 2021 13:33
Last Modified: 03 Feb 2022 10:12
URI: https://arro.anglia.ac.uk/id/eprint/707070

Actions (login required)

Edit Item Edit Item